8878 Stories, most recent news story added 2 hours 15 minutes ago
The U.S. Food and Drug Administration on Friday approved a highly anticipated blood thinner from Eli Lilly, though the drug must carry the agency's sternest warning because of its bleeding risks.
The Food and Drug Administration on Friday approved a highly anticipated blood thinner from Eli Lilly, though the drug must carry the agency's sternest warning because of its bleeding risks.
The investigation of the E. coli outbreak linked to Nestle Toll House cookie dough is nearly over, according to the U.S. Food and Drug Administration. The cause of the contamination has not been identified.
FRIDAY, July 10 (HealthDay News) -- The U.S. Food and Drug Administration has approved the Eli Lilly blood-thinner Effient (prasugrel) to prevent clots in people who have an artery-clearing procedure called angioplasty.
Effient will become the first real competition to Plavix, a blood thinner made by Sanofi-Aventis and Bristol-Myers Squibb.
FDA says a Plavix rival called Effient can be sold, but must carry a stern warning.
Lilly’s medicine, prasugrel, was cleared by the Food and Drug Administration and will be sold under the name Effient, the agency said today in an e-mail. The drug will carry the FDA’s strictest warning, known as a black box, to doctors about an increased risk of potentially fatal bleeding.
The medical device maker said Friday that it was recalling specific lots of its Paradigm Quick Set infusion sets because they may not work properly.
The strain of E. coli that sickened at least 69 people in 30 states doesn't match the strain found in a sample of raw cookie dough from the Nestlé USA plant in Danville, Va., says the U.S. Food and Drug Administration, the Associated Press reported.
MOORESTOWN, Pa., July 10 (UPI) -- The Food and Drug Administration is checking a Pennsylvania factory following the death of a worker who fell into a vat of boiling chocolate.
(Adds comment from Bristol-Myers spokeswoman.) The U.S. Food and Drug Administration approved the blood-thinning drug Effient on Friday in a long-awaited victory for its co-developers, Eli Lilly & Co. (LLY) and Daiichi Sankyo Co. (4568.TO).
(Adds comments from Lilly executives beginning in 6th paragraph.) The U.S. Food and Drug Administration approved the blood-thinning drug Effient on Friday in a long-awaited victory for its co-developers, Eli Lilly & Co. (LLY) and Daiichi Sankyo Co. (4568.TO).
The Food and Drug Administration said Thursday the strain of E. coli found in a sample of raw cookie dough collected at a Nestle USA manufacturing plant does not match the strain that has been linked to a 30-state outbreak, and they aren't sure how the dough was contaminated.
(Adds analyst reaction in fifth paragraph and additional background information.) The U.S. Food and Drug Administration approved the blood-thinning drug Effient on Friday in a long-awaited victory for its co-developers, Eli Lilly & Co. (LLY) and Daiichi Sankyo Co. (4568.TO).
The Food and Drug Administration has approved a highly anticipated blood thinner from Eli Lilly after more than 18 months of review.
The U.S. Food and Drug Administration approved the blood-thinning drug Effient on Friday in a long-awaited victory for its co-developers, Eli Lilly & Co. (LLY) and Daiichi Sankyo Co. (4568.TO).
